FindTrial
Sign In

The effect of thalidomide on children with beta-thalassemia intermedia and major: a retrospective study

The effect of thalidomide on children with beta-thalassemia intermedia and major: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031436
Enrollment
Unknown
Registered
2020-03-31
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beta-thalassemia

Interventions

case series:N/A

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Aged 5-18 years; 2. Diagnosis of beta-thalassemia intermedia and major; 3. Guardians have signed the informed consent form; 4. Not participating in other clinical research projects in three months before enrollment; 5. Not taking other drugs such as hydroxyurea that interfered with the therapeutic effect.

Exclusion criteria

Exclusion criteria: 1. Combined with liver, kidney and heart dysfunction; 2. Combined with megaloblastic anemia or other types of anemia; 3. Combined with malignant tumor diseases or rheumatic immunological diseases.

Design outcomes

Primary

MeasureTime frame
Hemoglobin;Transfusion;Hemoglobin composition;—

Secondary

MeasureTime frame
Serum ferritin;—

Countries

China

Contacts

Public ContactJianpei Fang

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

fangjpei@mail.sysu.edu.cn+86 20-81332213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026